JUN 13, 2016 3:01 PM PDT

Personalized Treatment For People With Depression?

WRITTEN BY: Xuan Pham
Depression affects millions of people worldwide, yet it’s an illness that’s still highly stigmatized. As with many illnesses, some patients respond to treatment and some don’t. But a new research suggests that testing patients for inflammatory biomarkers could reveal those who could benefit from more aggressive medication regimen.
    First of its kind test could personalize depression treatment | pixabay.com
 Clinical depression is different than sadness following a traumatic life event, such as the loss of a loved one. Patients with clinical depression are diagnosed by trained physicians based on criteria set by the Diagnostic and Statistical Manual of Mental Disorders (DSM). Currently, an estimated 14.8 million Americans are afflicted with depression. And as the mental condition is tied to physical wellness, the incidence of depression is ever increasing.
 
Generally, patients with depression are treated with a combination of medication (antidepressants) and psychological counseling. But the success rate of these treatments is variable, and doctors often have to engage through trial and error to arrive at the correct medication dose for their patients. Could blood-borne biomarkers eliminate this trial and error?
 
Based on the belief that inflammation drives stress which interferes with the actions of antidepressants, researchers at the King’s College London wondered whether inflammatory proteins could point to hard-to-treat cases. They looked at 140 people with depression, and isolated two biomarkers of inflammation: macrophage migration inhibitory factor (MIF), and interleukin-1beta.
 
In their study, the researchers found presence of these two biomarkers corresponded with decreased response to treatment. That is, patients with high levels of these proteins were less likely to respond to traditional antidepressants like selective serotonin reuptake inhibitors (SSRIs) and tricyclic compounds.
 

"About a third of patients might have these inflammatory markers and they would be people we might encourage to go on more aggressive treatment," said Carmine Pariante, the senior study author.
 
By contrast, the biomarker could alert doctors to go easy on those who are more likely to respond to the medications. After all, antidepressants may be safe, but they are not without side-effects. "We would not want to go in prescribing too much medicine if it's not necessary, but we would want to escalate people sooner rather than later if they need it," said Pariante.
 
Some caveats of the study include the limited size and the need for validation in a larger clinical trial. But the team is excited, as this is the first study of its kind to point towards personalized therapy for a mental illness like depression. "Being able to target those people with depression who don't respond to medication would be one of the most exciting steps forward in the treatment of mental illness for decades," said Marjorie Wallace, chief executive of SANE, a UK mental health charity organization.

Additional source: BBC
About the Author
I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 06, 2022
Clinical & Molecular DX
Researchers Confirm the Impact of Gut Viruses on Inflammatory Bowel Disease
JUN 06, 2022
Researchers Confirm the Impact of Gut Viruses on Inflammatory Bowel Disease
The gut microbiome refers to the collection of microorganisms that reside within the gut. The gut microbiome is known to ...
JUN 12, 2022
Cannabis Sciences
Cannabis Users Need More Sedation During Gastric Endoscopy
JUN 12, 2022
Cannabis Users Need More Sedation During Gastric Endoscopy
A presentation at the 2022 Digestive Disease Week showed evidence that cannabis consumers require higher levels of anest ...
JUN 16, 2022
Genetics & Genomics
One in 500 Men Carry an Extra Sex Chromosome
JUN 16, 2022
One in 500 Men Carry an Extra Sex Chromosome
Humans carry 46 chromosomes. We get one from each parent, making 22 pairs of autosomal chromosomes, and one pair of sex ...
JUN 21, 2022
Clinical & Molecular DX
Childhood Bronchitis Linked to Pneumonia and Lung Issues in Adulthood
JUN 21, 2022
Childhood Bronchitis Linked to Pneumonia and Lung Issues in Adulthood
Over 50 years ago, researchers began gathering data for the Tasmanian Longitudinal Health Study (TAHS). The TAHS, which ...
JUN 22, 2022
Technology
Alzheimer's Diagnosis With a Single MRI Scan
JUN 22, 2022
Alzheimer's Diagnosis With a Single MRI Scan
Alzheimer’s, one of the more common forms of dementia, is a condition for which there is currently no cure. Accord ...
AUG 07, 2022
Microbiology
Paralytic Polio Case ID'ed in New York & Health Officials are Concerned
AUG 07, 2022
Paralytic Polio Case ID'ed in New York & Health Officials are Concerned
Polio is a disease caused by the poliovirus. Polio can cause flu-like symptoms like nausea, headache, fever, and sore th ...
Loading Comments...